Healthcare Industry News: colorectal cancer
News Release - July 20, 2015
Applied Proteomics Appoints Robert C. Verfurth as Vice President, SalesSAN DIEGO, July 20, 2015 -- (Healthcare Sales & Marketing Network) -- Applied Proteomics Inc., a developer of protein-based molecular diagnostics, announced today the appointment of Robert C. Verfurth as the company's vice president of sales. Mr. Verfurth has more than 25 years of experience in sales leadership in the clinical laboratory, medical instrument and pharmaceutical industries, including positions with Innovus Pharmaceuticals, Inc., Apricus Biosciences, Inc., GeneOhm Sciences, Inc., BD Diagnostics, Prometheus Laboratories Inc. and Dianon Systems, Inc.
"Robert's extensive knowledge of the clinical diagnostics space will be a tremendous asset as Applied Proteomics advances our products into that arena," said Peter Klemm, Ph.D., president and CEO of Applied Proteomics. "His leadership experience will be critical as we expand our sales capabilities and ramp up commercial production."
Applied Proteomics recently partnered with InVentiv Health, a contract commercial organization, in order to help establish a sales force. The company is developing a non-invasive blood test for early detection of colorectal cancer, one of the most deadly yet preventable cancers if detected early.
"This is an exciting time to join Applied Proteomics, as they build a commercial team and grow into a true diagnostics company," said Mr. Verfurth. "I look forward to contributing to the growth of the company while bringing to market unique solutions that will help save lives."
Prior to joining Applied Proteomics Inc., Mr. Verfurth was vice president, sales and marketing for Innovus Pharmaceuticals, Inc., where he was responsible for a portfolio of prescription medicines and OTC consumer products. Previous to that, he was the vice president of sales of BQ kits and business development for Apricus Biosciences, Inc. Mr. Verfurth served as vice president, U.S. Sales and Support, for GeneOhm (acquired by BD Diagnostics in 2006), where he grew sales from ground up to $28 million, including launch of the first molecular diagnostic test for MRSA. He also held the positions of vice president of managed care and trade relations for Prometheus Laboratories Inc. and vice president of sales at Dianon Systems, Inc.
Mr. Verfurth has an M.S. in systems management from the University of Southern California and a B.S. in business administration from the University of Notre Dame.
About Applied Proteomics Inc.
Applied Proteomics Inc. is advancing the application of proteomics to the development of diagnostics, companion diagnostics, and personalized medicine applications to power better medical decisions and care. Applied Proteomics has developed a proteomics platform solution to make protein-based biomarker discovery possible as a replicable, industrial application ready to be applied to health diagnostic problems. Applied Proteomics' platform combines improved instrumentation, faster computing and extensive genome annotations with regimented standard operating procedures, extensive quality controls, and documented processes spanning hundreds of steps from sample collection to processing through informatics. Applied Proteomics is currently advancing several internal diagnostic development programs. Applied Proteomics is headquartered in San Diego.
For more information, please visit http://www.appliedproteomics.com.
Source: Applied Proteomics
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.